The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age
Open accessAbstract
Abstract The utility of X-inactivation based clonality assays for evaluation of human neoplasia is well-documented. However, excessive Lyonization is a potential limitation of these assays, because it mimics clonal derivation of cells. The incidence of excessive Lyonization in healthy females is controversial, with reported incidence varying from 4% to 33%. Several explanations have been offered for the observed variation, including different criteria for excessive Lyonization, diversity of X- linked clonality assays, small population sizes and more recently, tissue specificity of X-inactivation patterns. However, it is also possible that stem cell depletion, clonal hematopoiesis, or selection pressures on blood cells results in an increased incidence of excessive skewing. If any of the latter is true, then the incidence of excessive skewing should increase with age in blood cells. To test this hypothesis, we determined X-inactivation ratios at the human androgen receptor locus of 295 normal females from three age groups: (1) neonates, (2) females 28 to 32 years old and, (3) females aged > or = 60 years. The incidence of skewing (allele ratios > or = 3:1) was 8.6% (14 of 162) in neonates (P = .104 v 28 to 32); 16.4% (11/67) in 28 to 32 y.o. (P = .0064 v > or = 60), and 37.9% (25 of 66) in women > or = 60 y.o. (P < .0001 v neonates). When a more stringent criterion for skewing was used (allele ratios > or = 10:1), the incidence was 1.9% (3 of 162) in neonates (P = .362 v 28 to 32), 4.5% (3 of 67) in 28 to 32 y.o. (P = .0022 v > or = 60), and 22.7% (15 of 66) in > or = 60 y.o. group (P < .0001 v neonates). Results have been confirmed at the phosphoglycerate kinase locus for 48 heterozygous females. The incidence of excessive skewing increases with age. In neonates, the incidence is low and may correspond to true excessive Lyonization. Acquired skewing occurs with aging in normal females and is present in 38% of females over the age of 60. Further studies are needed to determine whether acquired skewing is a consequence of stem cell depletion, true clonal hematopoiesis, growth advantage conferred by parental-specific X-chromosomes, or other causes. These data provide an explanation for variation in reported incidence of excessive skewing in normal females. Furthermore, these findings suggest that any study of clonality using X-inactivation based assays should incorporate age- matched controls for Lyonization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“during aging, blood cells are derived from fewer and fewer stem cells.”
From Aging of hematopoietic stem cells (2018) · cites this paper as [79]
In the citing paper
“However, in some elderly individuals, HSCs acquire oncogenic mutations that allow them to outcompete their neighbors and clonally expand.”
From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Busque et al., 1996
In the citing paper
“As these HSCs clonally expand, they can account for a substantial fraction of steady state hematopoiesis, termed clonal hematopoiesis of indeterminate potential (CHIP) (Busque et al., 1996; Champion et al., 1997; Vas et al., 2012).”
From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Busque et al., 1996
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978
Allen, R. C., Zoghbi, H. Y., Moseley, A., Rosenblatt, H. M., & Belmont, J. W. (1992) · PubMed · Cited by 1,683
Clonal origin of chronic myelocytic leukemia in man.
Fialkow, P., Gartler, S. M., & Yoshida, A. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.4.1468 · Cited by 532
Clonal analysis using recombinant DNA probes from the X-chromosome.
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Preisinger, A. C., Willard, H. F., Michelson, A. M., Riggs, A. D., & Orkin, S. H. (1987) · PubMed · Cited by 417
Catalog Of Mutant Genes And Polymorphic Loci
Doolitile, D. P., Davisson, M. T., Guidi, J. N., & Green, M. C. (1996) · doi:10.1093/oso/9780198548690.003.0002 · Cited by 400
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
Linder, D., & Gartler, S. M. (1965) · Science · doi:10.1126/science.150.3692.67 · Cited by 398
Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell
Fialkow, P., Faguet, G., Jacobson, R., Vaidya, K., & Murphy, S. (1981) · Blood · doi:10.1182/blood.v58.5.916.916 · Cited by 384
Use of Restriction Fragment Length Polymorphisms to Determine the Clonal Origin of Human Tumors
Vogelstein, B., Fearon, E. R., Hamilton, S. R., & Feinberg, A. P. (1985) · Science · doi:10.1126/science.2982210 · Cited by 379
Kay, G. F., Penny, G. D., Patel, D., Ashworth, A., Brockdorff, N., & Rastan, S. (1993) · Cell · doi:10.1016/0092-8674(93)90658-d · Cited by 364
“Benign” Monoclonal Gammopathy—After 20 to 35 Years of Follow-Up
Kyle, R. A. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60015-9 · Cited by 344
Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin
Janssen, J. W. G., Buschle, M., Layton, M., Drexler, H. G., Lyons, J., BERGHE, H. V. D., Heimpel, H., Kubanek, B., Kleihauer, E., & Mufti, G. J. (1989) · Blood · doi:10.1182/blood.v73.1.248.248 · Cited by 313
Fialkow, P. J., Singer, J. W., Raskind, W. H., Adamson, J. W., Jacobson, R. J., Bernstein, I. D., Dow, L. W., Najfeld, V., & Veith, R. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708203170802 · Cited by 305
Evidence for a multistep pathogenesis of a myelodysplastic syndrome
Raskind, W. H., Tirumali, N., Jacobson, R., Singer, J., & Fialkow, P. (1984) · Blood · doi:10.1182/blood.v63.6.1318.1318 · Cited by 301
Tan, S., Williams, E. A., & Tam, P. (1993) · Nature Genetics · doi:10.1038/ng0293-170 · Cited by 239
Imprinting and X chromosome counting mechanisms determine Xist expression in early mouse development
Kay, G. F., Barton, S. C., Surani, M. A., & Rastan, S. (1994) · Cell · doi:10.1016/0092-8674(94)90049-3 · Cited by 235
Both X chromosomes function before visible X-chromosome inactivation in female mouse embryos
Epstein, C. J., SMITH, S. A., Travis, B., & Tucker, G. (1978) · Nature · doi:10.1038/274500a0 · Cited by 217
Primordial cell pool size and lineage relationships of five human cell types*
Fialkow, P. J. (1973) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1973.tb01813.x · Cited by 198
Tissue specificity of X-chromosome inactivation patterns
Gale, R. E., Wheadon, H., Boulos, P. B., & Linch, D. C. (1994) · Blood · doi:10.1182/blood.v83.10.2899.2899 · Cited by 175
Expression of the Gene Defect in X-Linked Agammaglobulinemia
Conley, M. E., Brown, P., Pickard, A. R., Buckley, R. H., Miller, D. S., Raskind, W. H., Singer, J. W., & Fialkow, P. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150907 · Cited by 171
Assessment of clonality in human tumors: a review.
Wainscoat, J. S., & Fey, M. F. (1990) · PubMed · Cited by 132
Tefferi, A., Thibodeau, S., & Solberg, L. J. (1990) · Blood · doi:10.1182/blood.v75.9.1770.1770 · Cited by 131
Behavior of hematopoietic stem cells in a large animal.
Abkowitz, J., Persik, M. T., Shelton, G. H., Ott, R. L., Kiklevich, J. V., Catlin, S. N., & Guttorp, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2031 · Cited by 124
Gale, R. E., Wheadon, H., & Linch, D. C. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb04521.x · Cited by 115
Carrier detection in the Wiskott Aldrich syndrome
Fearon, E., Kohn, D. B., Winkelstein, J. A., Vogelstein, B., & Blaese, R. M. (1988) · Blood · doi:10.1182/blood.v72.5.1735.1735 · Cited by 103
Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms.
Anger, B., Janssen, J. W. G., Schrezenmeier, H., Hehlmann, R., Heimpel, H., & Bartram, C. R. (1990) · PubMed · Cited by 89
The search for the mouse X-chromosome inactivation centre
Rastan, S., & Brown, S. D. M. (1990) · Genetics Research · doi:10.1017/s0016672300035163 · Cited by 80
An expression based clonality assay at the human androgen receptor locus (HUMARA) on chromosome X
Busque, L., Zhu, J., DeHart, D., Griffith, B. B., Willman, C. L., Carroll, R. S., Black, P. M., & Gilliland, D. G. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.4.697 · Cited by 71
Self-citationTsukamoto, N., Morita, K., Maehara, T., Okamoto, K., Karasawa, M., Omine, M., & Naruse, T. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb04695.x · Cited by 69
Wiggans, R. G., Jacobson, R., Fialkow, P., Woolley, P. V., Macdonald, J. S., & Schein, P. S. (1978) · PubMed · Cited by 61
X chromosome inactivation and the diagnosis of X linked disease in females.
Brown, R. M., & Brown, G. K. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.3.177 · Cited by 61
Evidence for clonal development of childhood acute lymphoblastic leukemia
Dow, L. W., Martin, P., Moohr, J., Greenberg, M., Macdougall, L., Najfeld, V., & Fialkow, P. (1985) · Blood · doi:10.1182/blood.v66.4.902.902 · Cited by 59
Abkowitz, J., Ott, R., Holly, R. D., & Adamson, J. (1988) · Blood · doi:10.1182/blood.v71.6.1687.1687 · Cited by 44
Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell
Fialkow, P., Faguet, G., Jacobson, R., et al. (1981) · Blood · doi:10.1182/blood.v58.5.916.bloodjournal585916 · Cited by 43
A novel clonality assay based on transcriptional analysis of the active X chromosome
Prchal, J. T., & Guan, Y. (1993) · Stem Cells · doi:10.1002/stem.5530110613 · Cited by 41
Insights into lymphocyte development from X-linked immune deficiencies
Belmont, J. W. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89012-5 · Cited by 26
Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin
Janssen, J. W. G., Buschle, M., Layton, M., et al. (1989) · Blood · doi:10.1182/blood.v73.1.248.bloodjournal731248 · Cited by 23
Evidence for a multistep pathogenesis of a myelodysplastic syndrome
Raskind, W., Tirumali, N., Jacobson, R., et al. (1984) · Blood · doi:10.1182/blood.v63.6.1318.bloodjournal6361318 · Cited by 23
Carrier detection in the Wiskott Aldrich syndrome
Fearon, E., Kohn, D. B., Winkelstein, J., et al. (1988) · Blood · doi:10.1182/blood.v72.5.1735.bloodjournal7251735 · Cited by 10
Tefferi, A., Thibodeau, S., & Solberg, L. J. (1990) · Blood · doi:10.1182/blood.v75.9.1770.bloodjournal7591770 · Cited by 10
Clonal haemopoiesis following cytotoxic therapy for lymphoma.
Cachia, P. G., Culligan, D. J., Clark, R. E., Whittaker, J. A., Jacobs, A., & Padua, R. A. (1993) · PubMed · Cited by 9
Evidence for clonal development of childhood acute lymphoblastic leukemia
Dow, L. W., Martin, P., Moohr, J., et al. (1985) · Blood · doi:10.1182/blood.v66.4.902.bloodjournal664902 · Cited by 8
Abkowitz, J., Ott, R., Holly, R., et al. (1988) · Blood · doi:10.1182/blood.v71.6.1687.bloodjournal7161687 · Cited by 8
Research works printed but not linked: 1
- Busque L, Gilliland DG: The PGK-PCR based clonality assay (PPCA), in Harwood AJ (ed): Methods in Molecular Biology: Proto- cols for Gene Analysis, vol 31. Totowa, NJ, Humana Press 1994, p 237
Cited by
Sorted by citations
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Coombs, C. C., Zehir, A., Devlin, S. M., Kishtagari, A., Syed, A., Jonsson, P., Hyman, D. M., Solit, D. B., Robson, M. E., Baselga, J., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.07.010 · Cited by 866
Prediction of acute myeloid leukaemia risk in healthy individuals
Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0317-6 · Cited by 850
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
Busque, L., Patel, J. P., Figueroa, M. E., Vasanthakumar, A., Provost, S., Hamilou, Z., Mollica, L., Li, J., Viale, A., Heguy, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2413 · Cited by 830
Self-citation
Metadata
- Authors
- Busque, L., Mio, R., Mattioli, J., Brais, E., Blais, N., Lalonde, Y., Maragh, M., & Gilliland, D.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- Research Center, Hopital Maisonneuve-Rosemont, University of Montreal, Quebec, Canada.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1996-07-01
- Volume
- 88
- Issue
- 1
- Pages
- 59-65
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W4242239767
- Cited by
- 543
- References
- 35
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 29 · 2020: 24 · 2019: 29 · 2018: 30 · 2017: 22 · 2016: 17 · 2015: 12 · 2014: 16 · 2013: 7 · 2012: 11
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA47261)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- X chromosome inactivation, X-inactivation skewing, heterozygous females, stem cell depletion, clonal hematopoiesis, neonates, healthy women, blood cells, X-inactivation patterns
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Base Sequence, Clone Cells, Dosage Compensation, Genetic, Female, Heterozygote, Humans, Infant, Newborn, Methylation, Middle Aged, Models, Biological, Molecular Sequence Data, Phosphoglycerate Kinase, Transcription Factors, Polymerase Chain Reaction, Artifacts, Cell Lineage, RNA, Untranslated, RNA, Long Noncoding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review